On June 2nd (Thursday), we welcomed Prof Margaret Sheil (President of QUT), Prof Mark Harvey (Vice-President of QUT), Mr. Takeshi Adachi (Queensland Trade Commissioner to Japan), and Ms. Annu Tamura (Senior Business Development Manager) to Hirotsu Bioscience headquarters in Tokyo.
During their visit, details of the progress that has been made on cancer-specific screening and the N-NOSE project in Japan were shared including progress on the large-scale clinical study for N-NOSE that is currently underway by QUT in Australia.
We have formed a business alliance with Sojitz Corporation.→PRESS RELEASE2022.03.11
We are pleased to announce our participation in i2.JP, an initiative launched by AstraZeneca to connect parties such as start-ups, healthcare pr . . .2022.03.11
We are pleased to announce that we have issued new shares to Aioi Nissay Dowa Insurance Co. through third party allocation. Both companies are l . . .2022.02.02